Repligen | RGEN - Fremdkapital

Aktienkurs
113.88
Täglich Wechseln
-3.73 -3.17%
Monatlich
-15.89%
Jährlich
-18.67%
Q1 Prognose
110.75




Fremdkapital Veränderung Datum
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio Techne USD 260M 40M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Bruker USD 1.85B 131.7M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 2M 2025-12
Exact Sciences USD 2.33B 9.34M 2025-09
General Electric Aerospace USD 18.81B 37M 2025-12
Henry Schein USD 2.31B 157M 2025-12
Illumina USD 1.49B 496M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Myriad Genetics USD 119.9M 400K 2025-12
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pfizer USD 57.41B 93M 2025-09
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Standard Biotools USD 299K 0 2025-12
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Waters USD 1.41B 460.24M 2025-12
West Pharmaceutical Services USD 202.8M 100K 2025-12